These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3307057)

  • 1. Engraftment of DLA-nonidentical bone marrow facilitated by recipient treatment with anti-class II monoclonal antibody and methotrexate.
    Deeg HJ; Sale GE; Storb R; Graham TC; Schuening F; Appelbaum FR; Thomas ED
    Transplantation; 1987 Sep; 44(3):340-5. PubMed ID: 3307057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of engraftment of DLA-nonidentical marrow by treatment of recipients with monoclonal antibody directed against marrow cells surviving radiation.
    Schuening F; Storb R; Goehle S; Meyer J; Graham TC; Deeg HJ; Appelbaum FR; Sale GE; Graf L; Loughran TP
    Transplantation; 1987 Nov; 44(5):607-13. PubMed ID: 3318032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engraftment of DLA-nonidentical unrelated canine marrow after high-dose fractionated total body irradiation.
    Deeg HJ; Storb R; Shulman HM; Weiden PL; Graham TC; Thomas ED
    Transplantation; 1982 Apr; 33(4):443-6. PubMed ID: 7041371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates.
    Deeg HJ; Storb R; Appelbaum FR; Kennedy MS; Graham TC; Thomas ED
    Transplantation; 1984 Jan; 37(1):62-5. PubMed ID: 6364490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation.
    Sandmaier BM; Storb R; Liu Y; Santos EB; Bryant E; Schuening FG; Deeg HJ; Seidel K; Graham T
    Transpl Immunol; 1996 Dec; 4(4):271-4. PubMed ID: 8972556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of intolerance.
    Deeg HJ; Storb R; Weiden PL; Raff RF; Sale GE; Atkinson K; Graham TC; Thomas ED
    Transplantation; 1982 Jul; 34(1):30-5. PubMed ID: 6750877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marrow graft studies in dogs: factors influencing resistance to engraftment and graft-versus-host disease.
    Deeg HJ; Storb R; Thomas ED
    Surv Immunol Res; 1982; 1(2):148-54. PubMed ID: 6764839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors.
    Storb R; Raff RF; Appelbaum FR; Deeg HJ; Fitzsimmons W; Graham TC; Pepe M; Pettinger M; Sale G; van der Jagt R
    Transplantation; 1993 Oct; 56(4):800-7. PubMed ID: 7692635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
    Storb R; Yu C; Wagner JL; Deeg HJ; Nash RA; Kiem HP; Leisenring W; Shulman H
    Blood; 1997 Apr; 89(8):3048-54. PubMed ID: 9108426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts.
    Loughran TP; Raff RF; Graham TC; Appelbaum FR; Schuening FG; Sale GE; Storb R
    Exp Hematol; 1990 Nov; 18(10):1126-31. PubMed ID: 2209768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.
    Yu C; Storb R; Deeg HJ; Graham TC; Scheuning FG; Huss R; Seidel K; Fitzsimmons WE
    Bone Marrow Transplant; 1996 Apr; 17(4):649-53. PubMed ID: 8722370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitation of DLA-incompatible marrow grafts by donor-specific serum transferrin?
    Deeg HJ; Pierpaoli W; Arrighi S; Seidel K; Graham T; Huss R; Yu C; Myerson D; Schuening F; Storb R
    Transpl Immunol; 1996 Jun; 4(2):113-6. PubMed ID: 8843587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenectomy does not enhance engraftment of DLA-nonidentical marrow transplants.
    Raff RF; Loughran TP; Graham T; Pepe M; Johnston B; Sale GE; Storb R
    Exp Hematol; 1993 Feb; 21(2):385-7. PubMed ID: 8425577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of DLA-compatible and incompatible fetal liver hematopoietic cells in dogs.
    Cain G; Stitzel K; Gale R; Champlin R
    Transplantation; 1987 Dec; 44(6):742-7. PubMed ID: 2892290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of an anti-TCRalphabeta monoclonal antibody to control host-versus-graft reactions in canine marrow allograft recipients conditioned with low dose total body irradiation.
    Barsoukov AA; Moore PF; Storb R; Santos EB; Sandmaier BM
    Transplantation; 1999 May; 67(10):1329-35. PubMed ID: 10360586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow.
    Storb R; Kolb HJ; Deeg HJ; Weiden PL; Appelbaum F; Graham TC; Thomas ED
    Bone Marrow Transplant; 1986 Dec; 1(2):167-77. PubMed ID: 3332131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
    Deeg HJ; Severns E; Raff RF; Sale GE; Storb R
    Transplantation; 1987 Nov; 44(5):621-32. PubMed ID: 2961110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors.
    Raff RF; Deeg HJ; Loughran TP; Graham TC; Aprile JA; Sale GE; Storb R
    Blood; 1986 Oct; 68(4):861-8. PubMed ID: 3530349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone.
    Raff RF; Storb R; Graham T; Fidler JM; Sale GE; Johnston B; Deeg HJ; Pepe M; Schuening F; Appelbaum FR
    Transplantation; 1992 Nov; 54(5):813-20. PubMed ID: 1440847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.